DCM: Diet, Genetics, and the Grain-Free Controversy

Learning Objectives

• 1Differentiate genetic DCM (Doberman PDK4/TTN mutations, Great Dane, Irish Wolfhound) from diet-associated DCM with taurine deficiency, and explain why this distinction determines prognosis and guides supplementation decisions
• 2Interpret echocardiographic parameters for DCM diagnosis including FS%, EF by Simpson's method, ESVI, and EPSS, and apply Doberman Holter criteria (VPC thresholds of <50, 50-300, and >300 per 24 hours) to occult disease screening
• 3Apply the PROTECT trial findings to justify pimobendan use in occult DCM, and construct a complete Stage C treatment protocol including antiarrhythmic selection (sotalol, mexiletine) and monitoring for concurrent VPC burden
• 4Evaluate the FDA diet-associated DCM investigation accurately — distinguishing correlation from causation, identifying reporting bias limitations, and communicating the honest clinical recommendation for grain-free diet management
• 5Implement weight-tiered taurine supplementation, diet change protocol, and omega-3/CoQ10/magnesium adjuncts with explicit evidence-level framing for each intervention

Course Syllabus

1. 1
   Meet Jackson — The Golden Who Can't Keep UpPreview

   module-1-meet-jackson

   8 min
2. 2
   Pathophysiology — Genetics, Grain-Free, and What the FDA Actually Found

   module-2-pathophysiology

   9 min
3. 3
   Diagnostic Workup — Echocardiography, Holter, and the Numbers That Change Everything

   module-3-diagnostic-workup

   10 min